Back

Concomitant anti-platelet therapy in warfarin-treated patients undergoing cardiac rhythm device implantation: a secondary analysis of the BRUISE CONTROL trial

19 March 2019 (10:05 - 10:55)
Organised by:
Congress Presentation Part of: Moderated ePosters 15: Implantable device therapy : the good, the bad and the ugly Device Complications and Lead Extraction EHRA Premium Access EHRA 2019

About the speaker

Photo
Professor Vidal Essebag

McGill University Health Centre, Montreal (Canada)

7 More presentations in this session

Presentation thumbnail
Are the risk factors different in pocket- and systemic device infections? data from the danish pacemaker and ICD register on 79,091 patients
Doctor T. Olsen (Odense, DK)
Abstract Slides
Presentation thumbnail
Lead-related venous stenosis in CIED carriers - is there a chance for an effective use of venous approach for AV fistula and hemodialysis cathether? Findings of 2228 venographies before TLE.
Doctor M. Czajkowski (Lublin, PL)
Abstract
Presentation thumbnail
Port-a-caths infected or migrated, not removable by manual traction: the exit strategy of cardiac pacing leads extraction techniques
Doctor R. De Lucia (Pisa, IT)
Presentation thumbnail
Transvenous leads extraction in elderly
Professor A. Polewczyk (Kielce, PL)
Abstract Slides
Presentation thumbnail
Unexpected technical problems during transvenous lead extraction. The experience among 2841 TLE procedures.
Professor A. Kutarski (Katowice, PL)
Abstract Slides

Access the full session

Session thumbnail
Moderated ePosters 15: Implantable device therapy : the good, the bad and the ugly

The Event

Event poster

EHRA 2019

19 March 2019 10:05 CET
You may be interested in
thumbnail
Congress Session
Hot topics in lead extraction: addressing modern challenges and preventing future problems
thumbnail
Congress Session
Pacemaker (2)
thumbnail
Congress Session
Lead extraction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources